Knowledge Home Human Health Knowledge All Opinion Papers Popular science Interviews Filter Therapeutic areas COVID-19 Digestive health Apply Home Human Health Knowledge Immunogenicity and safety of PHH-1V COVID-19 vaccine as a heterologus booster in adolescents Home Human Health Knowledge Antibody and B-cell responses to PHH-1V81 XBB.1.16-adapted SARS-CoV-2 booster vaccination are associated with variant neutralization Home Human Health Knowledge Rethinking optimal immunogens to face SARS-CoV-2. Evolution through vaccination Home Human Health Knowledge Mechanism of action of an adjuvanted protein vaccine based on the RBD from SARS-CoV-2 Spike protein Home Human Health Knowledge 34th ECCMID Integrated Symposium, 2024: COVID-19 booster immunization Home Human Health Knowledge Variant-specific neutralising antibodies levels induced by the PHH-1 V SARS-CoV-2 vaccine (Bimervax®) by HIPRA Home Human Health Knowledge Safety and immunogenicity of a PHH-1V booster dose after different prime vaccination schemes against COVID-19: Phase III clinical trial final results up to one year Home Human Health Knowledge Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results Home Human Health Knowledge Safety and Immunogenicity of PHH-1V Booster Against SARS-CoV-2 Variants, Including Omicron Subvariants: Results from a Phase IIb Open-Label Extension Study Load more
